Efficacy of concentrated autologous platelet-derived growth factors in chronic lower-extremity wounds

Journal of the American Podiatric Medical Association

Volumn 96, Issue 6, 2006, Pages 482-488

  McAlee, Jody Peter ^a,b   Kaplan, Eric ^a   Persich, Glanni ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845289405     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/0960482     Document Type: Article

References (17)

1. ELDOR R, RAZ I, BEN YA, ET AL: New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies. Diabet Med 21: 1161, 2004.
2. PHILLIPS TJ: Successful methods of treating leg ulcers: the tried and true, plus the novel and new. Postgrad Med 105: 159, 1990.
3. AMINIAN B, SHAMS M, SOVEYD M, ET AL: Topical autologous platelet-derived growth factors in the treatment of chronic diabetic ulcers. Arch Iran Med (April): 3, 2000.
4. MARGOLIS DJ, KANTOR J, SANTANNA J, ET AL: Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24: 483, 2001.
5. TRENT JT, FALABELLA A, EAGLSTEIN WH, ET AL: Venous ulcers: pathophysiology and treatment options. Ostomy Wound Manage 51: 38, 2005.
6. ABBADE LP, LASTORIA S, DE ALMEIDA ROLLO H, ET AL: A sociodemographic, clinical study of patients with venous ulcer. Int J Dermatol 44: 989, 2005.
7. AGREN MS, EAGLSTEIN WH, FERGUSON MW, ET AL: Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl (Stockh) 210: 3, 2000.
8. RAFFETTO JD, VASQUEZ R, GOODWIN DG, ET AL: Mitogen-activated protein kinase pathway regulates cell proliferation in venous ulcer fibroblasts. Vasc Endovasc Surg 40: 59, 2006.
9. SIEGGREEN MY, KLINE RA: Arterial insufficiency and ulceration: diagnosis and treatment options. Nurse Pract 29: 46, 2004.
10. WEITZ JI, BYRNE J, CLAGETT GP, ET AL: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94: 3026, 1996.
11. BOUZA C, MUNOZ A, AMATE JM: Efficacy of modern dressings in the treatment of leg ulcers: a systematic review. Wound Repair Regen 13: 218, 2005.
12. SHARMA S, MCALEER JP: Debriding wounds with the Versajet hydrosurgery system. Podiatry Manage 24: 127, 2005.
13. FU X, Li X, CHENG B, ET AL: Engineered growth factors and cutaneous wound healing: success and possible questions in the past 10 years. Wound Repair Regen 13: 122, 2005.
14. Ross R, RAINES EW, BOWEN-POPE DF: The biology of platelet-derived growth factor. Cell 46: 155, 1986.
15. MULDER GD: Standardizing wound treatment procedures for advanced technologies. JAPMA 92: 7, 2002.
16. EPPLEY BL, WOODELL JE, HIGGINS J: Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 114: 1502, 2004.
17. CROVETTI G, MARTINELLI G, Issi M, ET AL: Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 30: 145, 2004.